Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor

Abstract

The Cbl proto-oncogene product is tyrosine phosphorylated in response to a wide variety of stimuli. Cbl and the Abl nonreceptor tyrosine kinase both bind to SH3 domains from the SH2/SH3 adaptor Nck, and are candidate effectors for Nck function. Numerous additional SH2- and SH3-domain-mediated interactions are also possible between Cbl, Abl, and Nck. We find that these three signaling proteins associate when overexpressed in mammalian cells and can regulate each other's activity. Co-expression of wt Cbl together with c-Abl, the activity of which is normally repressed in vivo, led to extensive Abl-dependent phosphorylation of Cbl. The major proline-rich region of Cbl was required for its phosphorylation by c-Abl, but not by a constitutively activated Abl mutant, suggesting Cbl activates c-Abl by engaging its SH3 domain. Efficient phosphorylation of Cbl and its stable association with Abl required the SH2 domain of Abl, suggesting that SH2-phosphotyrosine interactions prevent dissociation of active Abl from Cbl. We also show that overexpression of Nck could repress the phosphorylation of Cbl by Abl in vivo. Studies with Nck mutants suggested that the Nck SH2 domain is responsible for inhibiting the activity of Abl toward both Cbl and Nck itself, most likely by competing with the Abl SH2 for tyrosine-phosphorylated binding sites.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Adler CE, Miyoshi-Akiyama T, Aleman LM, Tanaka M, Smith JM, Mayer BJ . 2000 J. Biol. Chem. 275: 36472–36478

  • Agami R, Shaul Y . 1998 Oncogene 16: 1779–1788

  • Alexandropoulos K, Baltimore D . 1996 Genes Dev. 10: 1341–1355

  • Andoniou CE, Thien CB, Langdon WY . 1996 Oncogene 12: 1981–1989

  • Andoniou CE, Thien CBF, Langdon WY . 1994 EMBO J. 13: 4515–4523

  • Barilá D, Superti-Furga G . 1998 Nature Genet. 18: 280–282

  • Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ . 1997 J. Biol. Chem. 272: 16170–16175

  • Blake TJ, Shapiro M, Morse HC, Langdon WY . 1991 Oncogene 6: 653–657

  • Burnham MR, Bruce-Staskal PJ, Harte MT, Weidow CL, Ma A, Weed SA, Bouton AH . 2000 Mol. Cell. Biol. 20: 5865–5878

  • Dai Z, Pendergast AM . 1995 Genes Dev. 9: 2569–2582

  • de Jong R, ten Hoeve J, Heisterkamp N, Groffen J . 1995 J. Biol. Chem. 270: 21468–21471

  • Duyster J, Baskaran R, Wang JYJ . 1995 Proc. Natl. Acad. Sci. USA 92: 1555–1559

  • Feller SM, Knudsen B, Hanafusa H . 1994 EMBO J. 13: 2341–2351

  • Franz WM, Berger P, Wang JYJ . 1989 EMBO J. 8: 137–147

  • Fukazawa T, Miyake S, Band V, Band H . 1996 J. Biol. Chem. 271: 14554–14559

  • Galisteo ML, Dikic I, Batzer AG, Langdon WY . 1995 J. Biol. Chem. 270: 20242–20245

  • Goff SP, Gilboa E, Witte ON, Baltimore D . 1980 Cell 22: 777–785

  • Izadi KD, Erdreich-Epstein A, Liu Y, Durden DL . 1998 Exp. Cell. Res. 15: 330–342

  • Jackson P, Baltimore D . 1989 EMBO J. 8: 449–456

  • Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC . 1999 Science 286: 309–312

  • Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, Miczek KA, Baltimore D . 1998 Neuron 21: 1259–1272

  • Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HC . 1989 Proc. Natl. Acad. Sci. USA 86: 1168–1172

  • Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y . 1999 Mol. Cell. 4: 1029–1040

  • Li W, Hu E, Skolnik EY, Ullrich A, Schlessinger J . 1992 Mol. Cell. Biol. 12: 5824–5833

  • Majidi M, Hubbs AE, Lichy JH . 1998 J. Biol. Chem. 273: 16608–16614

  • Mayer BJ, Baltimore D . 1994 Mol. Cell. Biol. 14: 2883–2894

  • Mayer BJ, Hirai H, Sakai R . 1995 Curr. Biol. 5: 296–305

  • Mayer BJ, Jackson PK, Baltimore D . 1991 Proc. Natl. Acad. Sci. USA 88: 627–631

  • McCarty JH . 1998 Bioessays 20: 913–921

  • Meisner H, Czech MP . 1995 J. Biol. Chem. 270: 25332–25335

  • Meisner H, Daga A, Buxton J, Fernandez B, Chawla A, Banerjee U, Czech MP . 1997 Mol. Cell. Biol. 17: 2217–2225

  • Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ . 1999 Nature 398: 84–90

  • Mes-Masson A-M, McLaughlin J, Daley GQ, Paskind M, Witte ON . 1986 Proc. Natl. Acad. Sci. USA 83: 9768–9772

  • Miyake S, Lupher Jr. ML, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H . 1997 Crit. Rev. Oncogenesis 8: 189–218

  • Moarefi I, LeFevre-Bernt M, Sicheri F, Huse M, Lee C-H, Kuriyan J, Miller WT . 1997 Nature 385: 650–653

  • Morgenstern JP, Land H . 1990 Nucleic Acids Res. 18: 3587–3596

  • Muller AJ, Pendergast AM, Havlik MH, Puil L, Pawson T, Witte ON . 1992 Mol. Cell. Biol. 12: 5087–5093

  • Ota Y, Samuelson LE . 1997 Science 276: 418–420

  • Park D, Rhee SG . 1992 Mol. Cell. Biol. 12: 5816–5823

  • Parrini MC, Mayer BJ . 1999 Chem. Biol. 6: 679–687

  • Pawson T, Scott JD . 1997 Science 278: 2075–2080

  • Payne G, Shoelson SE, Gish GD, Pawson T, Walsh CT . 1993 Proc. Natl. Acad. Sci. USA 90: 4902–4906

  • Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F, Witte ON . 1991 Proc. Natl. Acad. Sci. USA 88: 5927–5931

  • Ponticelli AS, Whitlock CA, Rosenberg N, Witte ON . 1982 Cell 29: 953–960

  • Raffel GD, Parmar K, Rosenberg N . 1996 J. Biol. Chem. 271: 4640–4645

  • Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H . 1996 J. Biol. Chem. 271: 8435–8442

  • Ren R, Ye Z-S, Baltimore D . 1994 Genes Dev. 8: 783–795

  • Rivero-Lezcano OM, Sameshima JH, Marcilla A, Robbins KC . 1994 J. Biol. Chem. 269: 17363–17366

  • Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T, Kay LE . 1995 Nature 374: 477–479

  • Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li J-L, Prasad KV, Griffin JD . 1996 Oncogene 12: 839–846

  • Schwartzenberg PL, Stall A, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP . 1991 Cell 65: 1165–1175

  • Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin MF . 1997 Nature 387: 520–523

  • Shi Y, Alin K, Goff SP . 1995 Genes Dev. 9: 2583–2597

  • Shishido T, Akagi T, Ouchi T, Georgescu M-M, Langdon WY, Hanafusa H . 2000 Proc. Natl. Acad. Sci. USA 97: 6439–6444

  • Shtivelman E, Lifshitz B, Gale RP, Canaani E . 1985 Nature 315: 550–554

  • Sicheri F, Moarefi I, Kuriyan J . 1997 Nature 385: 602–609

  • Smith JM, Katz S, Mayer BJ . 1999 J. Biol. Chem. 274: 27956–27962

  • Tanaka M, Gupta R, Mayer BJ . 1995a Mol. Cell. Biol. 15: 6829–6837

  • Tanaka M, Lu W, Gupta R, Mayer BJ . 1997 Proc. Natl. Acad. Sci. USA 94: 4493–4498

  • Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, Matsuda M . 1994 Proc. Natl. Acad. Sci. USA 91: 3443–3447

  • Tanaka S, Neff L, Baron R, Levy JB . 1995b J. Biol. Chem. 270: 14347–14351

  • Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC . 1991 Cell 65: 1153–1163

  • Van Etten RA . 1999 Trends Cell. Biol. 9: 179–186

  • Van Etten RA, Debnath J, Zhou H, Casasnovas JM . 1995 Oncogene 10: 1977–1988

  • Waterman H, Levkowitz G, Alroy I, Yarden Y . 1999 J. Biol. Chem. 274: 22151–22154

  • Wen S-T, Van Etten RA . 1997 Genes Dev. 11: 2456–2467

  • Wunderlich L, Goher A, Farago A, Downward J, Buday L . 1999 Cell. Signal. 11: 253–262

  • Xing L, Ge C, Zeltser R, Maskevitch G, Mayer BJ, Alexandropoulos K . 2000 Mol. Cell. Biol. 20: 7363–7377

  • Xu W, Harrison SC, Eck MJ . 1997 Nature 385: 595–602

  • Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R . 1999 J. Biol. Chem. 274: 31707–31712

  • Yoon CH, Lee J, Jongeward GD, Sternberg PW . 1995 Science 269: 1102–1105

  • Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL . 1994 Cell 76: 933–945

  • Zhu J, Shore SK . 1996 Mol. Cell. Biol. 16: 7054–7062

Download references

Acknowledgements

We thank MC Parrini and JJ Owen for critical reading of this manuscript; H Hanafusa, T Shishido, and AH Bouton for generously communicating results prior to publication; M Matsuda for monoclonal anti-GST antibody; and H Band for the human Cbl cDNA clone. T Miyoshi-Akiyama, CE Adler, and BJ Mayer were supported by the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health grant CA82258 to BJ Mayer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruce J Mayer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyoshi-Akiyama, T., Aleman, L., Smith, J. et al. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene 20, 4058–4069 (2001). https://doi.org/10.1038/sj.onc.1204528

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204528

Keywords

Search

Quick links